Dry Eye Disease

Anat Galor is a staff physician at the Miami VAMC and a Professor of Ophthalmology at the Bascom Palmer Eye Institute, University of Miami. Dr. Galor received an undergraduate degree from Carnegie Mellon University in 1997 and a medical doctorate degree at Washington University School of Medicine in 2002. She pursued residency training in ophthalmology at the Cleveland Cole Eye Institute (2006) followed by fellowship training in uveitis at the Wilmer Eye Institute, Johns Hopkins University (2007) and fellowship training in cornea, external disease, and refractive surgery at the Bascom Palmer Eye Institute (2008). Dr. Galor is the author of numerous publications that focus on dry eye, ocular surface tumors, and cornea. Dr. Galor's research has focused on understanding mechanisms of pain in dry eye, with an emphasis on studying new diagnostic and treatment modalities.

Section 1: What is Dry Eye Disease (DED)?

1

What is Dry Eye Disease: Evolving Definitions and Epidemiology

2

Questionnaires Used to Assess Dry Eye Disease

3

Clinical Assessment of Dry Eye Disease: Tear Film and Ocular Surface Health

4

Clinical Assessment of Dry Eye Disease: Nerve Health

5

Pathophsiology of Dry Eye Disease using Animal Models

6

Pathophsiology of Dry Eye Disease using Human Models

Section 2: Dry Eye Disease (DED) in Specific Populations

7

Sjögrens and Dry Eye Disease

8

Graft versus Host and Dry Eye Disease

9

Meibomian Gland Dysfunction and Dry Eye Disease

10

Systemic Pain Conditions and Dry Eye Disease

11

Ocular Conditions and Dry Eye Disease

Section 3: Treatment of Dry Eye Disease (DEF)

12

Treatment of Dry Eye Disease in the United States

13

Treatment of Dry Eye Disease in Asia

14

Treatment of Dry Eye Disease in Europe

15

Treatment of Ocular Pain Not Responsive to Traditional Dry Eye Disease Treatments